On Tuesday, Merck & Co. Inc. (NYSE:MRK) released topline results from the Phase 3 KEYNOTE-905 trial (also known as EV-303) in patients with muscle-invasive bladder cancer (MIBC) who are ineligible for ...

Key Takeaways Radical cystectomy involves bladder removal and urinary diversion, often using a laparoscopic robot-assisted approach for precision and access. The surgery lasts four to six hours, with ...

The researchers, led by Ahmed A. Hussein, MD, PhD, of Roswell Park Comprehensive Cancer Center in Buffalo, New York, randomized 77 patients undergoing robot-assisted radical cystectomy to receive ...

Radical cystectomy (RC) for muscle-invasive bladder cancer (MIBC) is associated with higher survival rates compared with trimodality therapy (TMT), a new meta-analysis finds. Although RC with ...